Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Pharming Group N.V. - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pharming Group N.V. - ADR market cap is $853.01M.
What is the 52-week high for Pharming Group N.V. - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pharming Group N.V. - ADR 52 week high is $17.08 as of October 10, 2025.
What is the 52-week low for Pharming Group N.V. - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pharming Group N.V. - ADR 52 week low is $7.31 as of October 10, 2025.
What is Pharming Group N.V. - ADR stock price today?
Pharming Group N.V. - ADR stock price today is $14.59.
What was Pharming Group N.V. - ADR stock price yesterday?
Pharming Group N.V. - ADR stock price yesterday was $14.37.
What is the PE ratio of Pharming Group N.V. - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pharming Group N.V. - ADR’s P/E ratio is -130.88.
What is the Price-to-Book ratio of Pharming Group N.V. - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pharming Group N.V. - ADR P/B ratio is 4.3311.
What is the 50-day moving average of Pharming Group N.V. - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pharming Group N.V. - ADR 50-day moving average is $13.63.